OBJECTIVE: Walker-Warburg syndrome (WWS) is a genetically heterogeneous congenital muscular dystrophy caused by abnormal glycosylation of alpha-dystroglycan (alpha-DG) that is associated with brain malformations and eye anomalies. The Fukutin (FKTN) gene, which causes autosomal recessively inherited WWS is most often associated with Fukuyama congenital muscular dystrophy in Japan. We describe the clinical features of four nonconsanguinous Ashkenazi Jewish families with WWS and identify the underlying genetic basis for WWS. METHOD: We screened for mutations in POMGnT1, POMT1, POMT2, and FKTN, genes causing WWS, by dideoxy sequence analysis. RESULTS: We identified an identical homozygous c.1167insA mutation in the FKTN gene on a common haplotype in all four families and identified 2/299 (0.7%) carriers for the c.1167insA mutation among normal American Ashkenazi Jewish adults. CONCLUSION: These data suggest that the c.1167insA FKTN mutation described by us is a founder mutation that can be used to target diagnostic testing and carrier screening in the Ashkenazi Jewish population. Copyright (c) 2009 John Wiley & Sons, Ltd.
OBJECTIVE:Walker-Warburg syndrome (WWS) is a genetically heterogeneous congenital muscular dystrophy caused by abnormal glycosylation of alpha-dystroglycan (alpha-DG) that is associated with brain malformations and eye anomalies. The Fukutin (FKTN) gene, which causes autosomal recessively inherited WWS is most often associated with Fukuyama congenital muscular dystrophy in Japan. We describe the clinical features of four nonconsanguinous Ashkenazi Jewish families with WWS and identify the underlying genetic basis for WWS. METHOD: We screened for mutations in POMGnT1, POMT1, POMT2, and FKTN, genes causing WWS, by dideoxy sequence analysis. RESULTS: We identified an identical homozygous c.1167insA mutation in the FKTN gene on a common haplotype in all four families and identified 2/299 (0.7%) carriers for the c.1167insA mutation among normal American Ashkenazi Jewish adults. CONCLUSION: These data suggest that the c.1167insAFKTN mutation described by us is a founder mutation that can be used to target diagnostic testing and carrier screening in the Ashkenazi Jewish population. Copyright (c) 2009 John Wiley & Sons, Ltd.
Authors: D Beltrán-Valero de Bernabé; H van Bokhoven; E van Beusekom; W Van den Akker; S Kant; W B Dobyns; B Cormand; S Currier; B Hamel; B Talim; H Topaloglu; H G Brunner Journal: J Med Genet Date: 2003-11 Impact factor: 6.318
Authors: E Kondo-Iida; K Kobayashi; M Watanabe; J Sasaki; T Kumagai; H Koide; K Saito; M Osawa; Y Nakamura; T Toda Journal: Hum Mol Genet Date: 1999-11 Impact factor: 6.150
Authors: K Kobayashi; J Sasaki; E Kondo-Iida; Y Fukuda; M Kinoshita; Y Sunada; Y Nakamura; T Toda Journal: FEBS Lett Date: 2001-02-02 Impact factor: 4.124
Authors: D Beltran-Valero de Bernabé; T Voit; C Longman; A Steinbrecher; V Straub; Y Yuva; R Herrmann; J Sperner; C Korenke; C Diesen; W B Dobyns; H G Brunner; H van Bokhoven; M Brockington; F Muntoni Journal: J Med Genet Date: 2004-05 Impact factor: 6.318
Authors: Daniel Beltrán-Valero de Bernabé; Sophie Currier; Alice Steinbrecher; Jacopo Celli; Ellen van Beusekom; Bert van der Zwaag; Hülya Kayserili; Luciano Merlini; David Chitayat; William B Dobyns; Bru Cormand; Ana-Elina Lehesjoki; Jesús Cruces; Thomas Voit; Christopher A Walsh; Hans van Bokhoven; Han G Brunner Journal: Am J Hum Genet Date: 2002-10-04 Impact factor: 11.025
Authors: Peter B Kang; Leslie Morrison; Susan T Iannaccone; Robert J Graham; Carsten G Bönnemann; Anne Rutkowski; Joseph Hornyak; Ching H Wang; Kathryn North; Maryam Oskoui; Thomas S D Getchius; Julie A Cox; Erin E Hagen; Gary Gronseth; Robert C Griggs Journal: Neurology Date: 2015-03-31 Impact factor: 9.910
Authors: Rebecca L Puckett; Steven A Moore; Thomas L Winder; Tobias Willer; Stephen G Romansky; Kelly King Covault; Kevin P Campbell; Jose E Abdenur Journal: Neuromuscul Disord Date: 2009-04-01 Impact factor: 4.296
Authors: Manuel A Rivas; Brandon E Avila; Jukka Koskela; Hailiang Huang; Christine Stevens; Matti Pirinen; Talin Haritunians; Benjamin M Neale; Mitja Kurki; Andrea Ganna; Daniel Graham; Benjamin Glaser; Inga Peter; Gil Atzmon; Nir Barzilai; Adam P Levine; Elena Schiff; Nikolas Pontikos; Ben Weisburd; Monkol Lek; Konrad J Karczewski; Jonathan Bloom; Eric V Minikel; Britt-Sabina Petersen; Laurent Beaugerie; Philippe Seksik; Jacques Cosnes; Stefan Schreiber; Bernd Bokemeyer; Johannes Bethge; Graham Heap; Tariq Ahmad; Vincent Plagnol; Anthony W Segal; Stephan Targan; Dan Turner; Paivi Saavalainen; Martti Farkkila; Kimmo Kontula; Aarno Palotie; Steven R Brant; Richard H Duerr; Mark S Silverberg; John D Rioux; Rinse K Weersma; Andre Franke; Luke Jostins; Carl A Anderson; Jeffrey C Barrett; Daniel G MacArthur; Chaim Jalas; Harry Sokol; Ramnik J Xavier; Ann Pulver; Judy H Cho; Dermot P B McGovern; Mark J Daly Journal: PLoS Genet Date: 2018-05-24 Impact factor: 5.917